Skip to Main Content

As experimental drugs continue to fail in Alzheimer’s patients, research interest has increasingly shifted to finding a way to stop the disease long before it erodes people’s cognitive abilities.

But how do you identify the right people to target?

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!